Consensus is taking fax data, received by rural clinics, post acute, substance abuse clinics, home health et al, and helping them put it into their systems of records–which are in general not FHIR-enabled. They allow those facilities & services to receive referrals from acute care hospitals. By 2027 many of these standards are going to…
Rural hospital leaders are questioning whether they can continue to afford to do business with Medicare Advantage companies, and some say the only way to maintain services and protect patients is to end their contracts with the private insurers. Medicare Advantage plans pay hospitals lower rates than traditional Medicare, said Jason Merkley, CEO of Brookings…
When the catastrophic Los Angeles fires broke out, John Volckens suspected firefighters and residents were breathing toxic air from the burning homes, buildings, and cars, but it was unclear how much risk the public faced. So, the professor of environmental health at Colorado State University devised a plan to get answers. Volckens shipped 10 air…
Healthcare leaders hope Dr. Oz supports Medicare Advantage, nutrition and telehealth as CMS administrator. The post What Issues Do Healthcare Leaders Want Dr. Oz to Tackle as CMS Administrator? appeared first on MedCity News.
Rhythm Pharmaceuticals drug Imcivree met the body mass index reduction goals of a Phase 3 test in hypothalamic obesity, an acquired form of obesity stemming from dysregulation of the MC4R pathway in the hypothalamus. The engineered peptide drug is already approved for two genetically driven types of obesity. The post Rhythm Pharma Drug Lowers BMI…
APG CEO Susan Dentzer believes that now is indeed the time to act to improve Medicare and Medicare Advantage
Walter Singleterry has worked as a member of the Environmental Services at Baptist Health Shelby Hospital for the last 14 years. Not long after after he was hired, Walter was promoted to cleaning patients’ rooms—a position he does not take lightly. Phyllis Thomas, a manager in the EVS department at Shelby Hospital, has worked at…
GSK is licensing an ABL Bio technology yields bispecific antibodies engineered to leverage a certain transmembrane receptor to cross the blood-brain barrier to treat neurodegeneration. GSK is already partnered with Alector, which has monoclonal antibodies in clinical development for Alzheimer’s disease. The post GSK Grabs Rights to Technology That Gets Drugs Across the Blood-Brain Barrier…
This slideshow examines how cost and insurance affects people’s access to care, including decisions to forgo or delay needed care and access to a usual source of care.
Public access to government records that document the handling of illnesses, faulty products, and safety lapses at health facilities will slow after mass firings at the federal Department of Health and Human Services swept out staff members responsible for releasing records, according to transparency advocates and health experts. HHS Secretary Robert F. Kennedy Jr.’s layoffs…